Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma

Ryo Maeda, Junji Yoshida, Genichiro Ishii, Tomoyuki Hishida, Mitsuyo Nishimura, Kanji Nagai

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: The objective of this study was to investigate the association between cigarette smoking, cancer survival, and pathological features of clinical stage IA lung adenocarcinoma. Methods: Between August 1992 and December 2007, 1,070 consecutive patients with clinical stage IA lung adenocarcinoma underwent complete resection with systematic lymph node dissection. Univariate analysis by log-rank tests was performed to determine unfavorable prognostic factors, and the Cox proportional hazards regression model was used to identify the potential independent predictors. Results: The overall 5-year survival rate of patients with greater than 20 pack-years (PY > 20) was 71%, significantly lower than patients with 20 or less pack-years (PY ≤ 20; 86%; p < 0.001). Postoperative pathological prognostic factors, including moderate or poor histologic differentiation, lymphatic permeation, intratumoral vascular invasion, visceral pleural invasion, and lymph node metastasis, were detected more often in patients with greater than 20 PY. Sixty-five percent of the patients in this study had pathological stage IA tumors, and their overall 5-year survival rates with 20 or less PY and greater than 20 PY were 97% and 86%, respectively (p < 0.001). Conclusions: In patients with clinical stage IA adenocarcinoma, a history of heavy smoking was associated with poor outcomes and was a statistically significant predictor of histologic tumor invasion.

Original languageEnglish
Pages (from-to)1626-1632
Number of pages7
JournalAnnals of Thoracic Surgery
Volume93
Issue number5
DOIs
Publication statusPublished - 2012 May
Externally publishedYes

Fingerprint

Smoking
Survival
Neoplasms
Survival Rate
Lymph Node Excision
Proportional Hazards Models
Blood Vessels
Adenocarcinoma of lung
Adenocarcinoma
Lymph Nodes
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma. / Maeda, Ryo; Yoshida, Junji; Ishii, Genichiro; Hishida, Tomoyuki; Nishimura, Mitsuyo; Nagai, Kanji.

In: Annals of Thoracic Surgery, Vol. 93, No. 5, 05.2012, p. 1626-1632.

Research output: Contribution to journalArticle

Maeda, Ryo ; Yoshida, Junji ; Ishii, Genichiro ; Hishida, Tomoyuki ; Nishimura, Mitsuyo ; Nagai, Kanji. / Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma. In: Annals of Thoracic Surgery. 2012 ; Vol. 93, No. 5. pp. 1626-1632.
@article{e37faddeff434c07ac94695efa602cbe,
title = "Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma",
abstract = "Background: The objective of this study was to investigate the association between cigarette smoking, cancer survival, and pathological features of clinical stage IA lung adenocarcinoma. Methods: Between August 1992 and December 2007, 1,070 consecutive patients with clinical stage IA lung adenocarcinoma underwent complete resection with systematic lymph node dissection. Univariate analysis by log-rank tests was performed to determine unfavorable prognostic factors, and the Cox proportional hazards regression model was used to identify the potential independent predictors. Results: The overall 5-year survival rate of patients with greater than 20 pack-years (PY > 20) was 71{\%}, significantly lower than patients with 20 or less pack-years (PY ≤ 20; 86{\%}; p < 0.001). Postoperative pathological prognostic factors, including moderate or poor histologic differentiation, lymphatic permeation, intratumoral vascular invasion, visceral pleural invasion, and lymph node metastasis, were detected more often in patients with greater than 20 PY. Sixty-five percent of the patients in this study had pathological stage IA tumors, and their overall 5-year survival rates with 20 or less PY and greater than 20 PY were 97{\%} and 86{\%}, respectively (p < 0.001). Conclusions: In patients with clinical stage IA adenocarcinoma, a history of heavy smoking was associated with poor outcomes and was a statistically significant predictor of histologic tumor invasion.",
author = "Ryo Maeda and Junji Yoshida and Genichiro Ishii and Tomoyuki Hishida and Mitsuyo Nishimura and Kanji Nagai",
year = "2012",
month = "5",
doi = "10.1016/j.athoracsur.2012.01.005",
language = "English",
volume = "93",
pages = "1626--1632",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma

AU - Maeda, Ryo

AU - Yoshida, Junji

AU - Ishii, Genichiro

AU - Hishida, Tomoyuki

AU - Nishimura, Mitsuyo

AU - Nagai, Kanji

PY - 2012/5

Y1 - 2012/5

N2 - Background: The objective of this study was to investigate the association between cigarette smoking, cancer survival, and pathological features of clinical stage IA lung adenocarcinoma. Methods: Between August 1992 and December 2007, 1,070 consecutive patients with clinical stage IA lung adenocarcinoma underwent complete resection with systematic lymph node dissection. Univariate analysis by log-rank tests was performed to determine unfavorable prognostic factors, and the Cox proportional hazards regression model was used to identify the potential independent predictors. Results: The overall 5-year survival rate of patients with greater than 20 pack-years (PY > 20) was 71%, significantly lower than patients with 20 or less pack-years (PY ≤ 20; 86%; p < 0.001). Postoperative pathological prognostic factors, including moderate or poor histologic differentiation, lymphatic permeation, intratumoral vascular invasion, visceral pleural invasion, and lymph node metastasis, were detected more often in patients with greater than 20 PY. Sixty-five percent of the patients in this study had pathological stage IA tumors, and their overall 5-year survival rates with 20 or less PY and greater than 20 PY were 97% and 86%, respectively (p < 0.001). Conclusions: In patients with clinical stage IA adenocarcinoma, a history of heavy smoking was associated with poor outcomes and was a statistically significant predictor of histologic tumor invasion.

AB - Background: The objective of this study was to investigate the association between cigarette smoking, cancer survival, and pathological features of clinical stage IA lung adenocarcinoma. Methods: Between August 1992 and December 2007, 1,070 consecutive patients with clinical stage IA lung adenocarcinoma underwent complete resection with systematic lymph node dissection. Univariate analysis by log-rank tests was performed to determine unfavorable prognostic factors, and the Cox proportional hazards regression model was used to identify the potential independent predictors. Results: The overall 5-year survival rate of patients with greater than 20 pack-years (PY > 20) was 71%, significantly lower than patients with 20 or less pack-years (PY ≤ 20; 86%; p < 0.001). Postoperative pathological prognostic factors, including moderate or poor histologic differentiation, lymphatic permeation, intratumoral vascular invasion, visceral pleural invasion, and lymph node metastasis, were detected more often in patients with greater than 20 PY. Sixty-five percent of the patients in this study had pathological stage IA tumors, and their overall 5-year survival rates with 20 or less PY and greater than 20 PY were 97% and 86%, respectively (p < 0.001). Conclusions: In patients with clinical stage IA adenocarcinoma, a history of heavy smoking was associated with poor outcomes and was a statistically significant predictor of histologic tumor invasion.

UR - http://www.scopus.com/inward/record.url?scp=84860239873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860239873&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2012.01.005

DO - 10.1016/j.athoracsur.2012.01.005

M3 - Article

C2 - 22421592

AN - SCOPUS:84860239873

VL - 93

SP - 1626

EP - 1632

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -